The biotechnology firm raised fresh capital to accelerate growth in American and European markets and complete new laboratory facilities.
Aelius Biotech
Aelius Biotech develops laboratory gut models to test drugs and foodstuffs without animal trials.
Aelius Biotech provides laboratory testing services using an innovative gut model to simulate human digestion for the food and pharmaceutical industries. The company was founded by university researchers to offer alternatives to animal testing.
Filed accounts
Cash at bank
Net assets
Shareholders' funds
Employees
Cash, assets and headcount from Aelius Biotech's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Founders

Peter Chater
CEO
Peter is the founder and CEO of Aelius Biotech, following academic research and fellowships at Newcastle University.
LinkedIn
Matt Wilcox
LinkedInJeff Pearson
Investors
- £750KNorth East FundFollow-on

- £1.3MNorth East FundLead

Funding history
The funding round was managed by Mercia Ventures and will support lab relocation and team expansion.